Institutional Ownership
Oramed Pharmaceuticals Inc
CUSIP 68403P203COM NEWORMPQ1 2026
Institutional Holders
64
13F filers
Shares Held
13.24M
Aggregate institutional
Institutional Value
$44.77M
Q1 2026
Net New Holders
+8
16 new · 8 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions16
Increased19
Decreased16
Sold out8
Institutional Holders
64 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Bml Capital Management, LLC | 3.17M | $10.77M | 0 | Held |
| 2 | Aquamarine Financial (Cayman) Ltd | 2.11M | $7.18M | +139.3K | Added |
| 3 | Mercer Global Advisors Inc /Adv | 1.91M | $6.50M | +1.91M | New |
| 4 | Gem Investment Advisors, LLC | 1.64M | $5.58M | −358.7K | Reduced |
| 5 | Murchinson Ltd. | 1.32M | $4.47M | −25.0K | Reduced |
| 6 | Boothbay Fund Management, LLC | 600.7K | $2.04M | −11.4K | Reduced |
| 7 | Marshall Wace, LLP | 259.6K | $882.7K | +556 | Added |
| 8 | Rathbones Group PLC | 233.0K | $792.3K | 0 | Held |
| 9 | Dimensional Fund Advisors LP | 158.2K | $537.7K | +7.7K | Added |
| 10 | Wells Fargo & Company/Mn | 157.6K | $535.8K | +27.0K | Added |
54 more institutional holders on Premium
See every fund holding Oramed Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders